Alzheimer's drug candidates reverse broader aging

CMS121 and J147, two drug candidates that improve memory and slow neurodegeneration associated with Alzheimer's disease, also slow aging in healthy, older mice. The compounds block damage to neurons caused by general aging and restore levels of specific molecules to those seen in younger animals.